Chemoinformaics analysis of cyclokievitone hydrate
| Molecular Weight | 372.373 | nRot | 1 |
| Heavy Atom Molecular Weight | 352.213 | nRig | 23 |
| Exact Molecular Weight | 372.121 | nRing | 4 |
| Solubility: LogS | -3.958 | nHRing | 2 |
| Solubility: LogP | 3.195 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 47 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 12 |
| nHA | 7 | APOL | 52.3499 |
| nHD | 4 | BPOL | 24.4041 |
| QED | 0.606 |
| Synth | 3.903 |
| Natural Product Likeliness | 2.635 |
| NR-PPAR-gamma | 0.95 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.007 |
| Pgp-sub | 0.126 |
| HIA | 0.022 |
| CACO-2 | -5.137 |
| MDCK | 0.00000976 |
| BBB | 0.024 |
| PPB | 0.988491 |
| VDSS | 0.434 |
| FU | 0.0188011 |
| CYP1A2-inh | 0.701 |
| CYP1A2-sub | 0.325 |
| CYP2c19-inh | 0.17 |
| CYP2c19-sub | 0.092 |
| CYP2c9-inh | 0.637 |
| CYP2c9-sub | 0.902 |
| CYP2d6-inh | 0.608 |
| CYP2d6-sub | 0.395 |
| CYP3a4-inh | 0.447 |
| CYP3a4-sub | 0.395 |
| CL | 9.843 |
| T12 | 0.28 |
| hERG | 0.026 |
| Ames | 0.07 |
| ROA | 0.588 |
| SkinSen | 0.855 |
| Carcinogencity | 0.333 |
| EI | 0.302 |
| Respiratory | 0.119 |
| NR-Aromatase | 0.356 |
| Antiviral | Yes |
| Prediction | 0.651607 |